Results 11 to 20 of about 142,808 (310)
Early complications after living donor nephrectomy: analysis of the Swiss Organ Living Donor Health Registry [PDF]
Swiss Medical Weekly, 2017 BACKGROUND We evaluated the prospectively collected data about the incidence of early peri- and postoperative complications, and potential risk factors for adverse outcomes after living kidney donation in Switzerland.
Felix Burkhalter +7 more
doaj +2 more sources
Living donor liver transplantation [PDF]
HPB, 2006 The introduction of living donor liver transplantation (LDLT) has been one of the most remarkable steps in the field of liver transplantation (LT). First introduced for children in 1989, its adoption for adults has followed only 10 years later. As the demand for LT continues to increase, LDLT provides life-saving therapy for many patients who would ...
Nadalin, S. +5 more
openaire +3 more sources
Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma
Frontiers in Immunology, 2022 Immunotherapy treatments, particularly immune checkpoint blockade, can result in benefits in clinical settings. But many pre-clinical and clinical studies have shown that resistance to anti-PD1 therapy frequently occurs, leading to tumor recurrence and ...
Xiangyi Kong +13 more
doaj +1 more source
, 2021 AIM: This qualitative study aimed to explore the donor-recipient relationships following living-donor liver ...
SARIGÖL ORDİN, YAPRAK +9 more
core +1 more source
Frontiers in Oncology, 2022 BackgroundHepatocellular carcinoma (HCC) is a highly heterogeneous tumor with several rare pathological subtypes and which is still poorly understood. This study aimed to describe the epidemiological and clinical spectrum of five rare HCC subtypes and ...
Xiaoyuan Chen +30 more
doaj +1 more source
STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
iScience, 2021 Summary: Serine/threonine kinase 39 (STK39) is overexpressed in various tumor tissues and plays an essential role in tumor progression. In this study, we investigated the clinical value, as well as the potential functions and mechanisms of STK39 in ...
Xiaopei Hao +9 more
doaj +1 more source
FER Regulated by miR-206 Promotes Hepatocellular Carcinoma Progression via NF-κB Signaling
Frontiers in Oncology, 2021 ObjectivesFeline sarcoma-related protein (FER) is known to play a critical regulatory role in several carcinomas. However, the exact biological function of FER in hepatocellular carcinoma (HCC) still needs to be investigated.
Wenzhou Ding +20 more
doaj +1 more source
An international comparison of deceased and living organ donation/transplant rates in opt-in and opt-out systems: a panel study [PDF]
, 2014 Background: Policy decisions about opt-in and opt-out consent for organ donation are based on limited evidence. To fill this gap we investigated the difference between deceased and living organ donation rates in opt-in and opt-out consent systems across ...
Ronan E O’Carroll +6 more
core +1 more source
Frontiers in Oncology, 2022 BackgroundThe evaluation of the nodal status of hepatocellular carcinoma (HCC) is a classic but controversial topic. This study aimed to investigate the incidence of lymph node metastasis (LNM), explore the role of lymph node dissection (LND), and ...
Xiaoyuan Chen +24 more
doaj +1 more source
Making sense of risk. Donor risk communication in families considering living liver donation to a child [PDF]
, 2009 This paper contributes to the growing line of thought in bioethics that respect for autonomy should not be equated to the facilitation of individualistic self determination through standard requirements of informed consent in all healthcare contexts. The
Verkerk, M. +5 more
core +1 more source